Catalyst Wire Dossier Catalyst Wire Dossier

Nivolumab in combination with chemotherapy

nivolumab · BMS
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nivolumab in combination with chemotherapy, covering 2020-10-19 to 2020-10-19. Get the full timeline:

Most recent: Clinical Trial Update: Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLC [Phase 2]

See pricing